Status:
WITHDRAWN
Evaluation of EverOn™ System in Medical / Surgical Ward
Lead Sponsor:
EarlySense Ltd.
Conditions:
Post Operative Patient
Patients Requiring PCA
Eligibility:
All Genders
18-85 years
Brief Summary
The EverOn™ system developed by EarlySense, Ltd., the sponsor of this study, is intended to assist hospitals to better address and improve recognition and response to changes in a patient's condition....
Eligibility Criteria
Inclusion
- Age above 18 years.
- Patients not monitored continuously by telemetry, vital sign monitor or oximetry.
- Patients not requiring special mattresses (e.g. airflow).
- The patient or a legal guardian is ready to sign the Informed Consent.
Exclusion
- Patients that at the judgment of the staff in the evaluating unit, are not able to communicate coherently and respond to nurses' questions.
- Patients monitored continuously by telemetry, vital sign monitor or oximetry.
- Patients requiring special mattresses.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00640718
Start Date
March 1 2008
End Date
May 1 2010
Last Update
July 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MetroWest Medical Center
Framingham, Massachusetts, United States, 01702-9167